|
| 主要出血 |
| 榫眼12莫 |
0.65 (0.24,1.29) |
0.67 (0.31,1.37) |
0.58 (0.31,1.13) |
0.76 (0.44,1.25) |
1.53 (0.95,2.75) |
| 1.54 (0.77,4.24) |
榫眼1 mo + P2Y12 |
1.03 (0.37,3.63) |
0.89 (0.36,3.08) |
1.18 (0.49,3.53) |
2.38 (1.05,8.20) |
| 1.50 (0.73,3.26) |
0.97 (0.28,2.67) |
榫眼3莫+亚撒 |
0.86 (0.34,2.41) |
1.13 (0.46,2.90) |
2.30 (1.00,6.28) |
| 1.73 (0.89,3.27) |
1.12 (0.32,2.78) |
1.16 (0.41,2.93) |
榫眼3莫+ P2Y12 |
1.31 (0.54,2.88) |
2.66 (1.17,6.36) |
| 1.32 (0.80,2.27) |
0.85 (0.28,2.02) |
0.89 (0.35,2.18) |
0.76 (0.35,1.85) |
榫眼6个月 |
2.04 (1.17,3.93) |
| 0.65 (0.36,1.05) |
0.42 (0.12,0.95) |
0.44 (0.16,1.00) |
0.38 (0.16,0.85) |
0.49 (0.25,0.85) |
L-DAPT |
|
| 任何出血 |
| 榫眼12莫 |
0.75 (0.37,1.16) |
0.73 (0.43,1.21) |
0.58 (0.37,0.87) |
0.72 (0.50,1.00) |
1.53 (1.05,2.12) |
| 1.33 (0.87,2.72) |
榫眼1 mo + P2Y12 |
0.98 (0.50,2.40) |
0.76 (0.43,1.79) |
0.97 (0.55,2.10) |
2.02 (1.18,4.33) |
| 1.37 (0.82,2.31) |
1.02 (0.42,1.99) |
榫眼3莫+亚撒 |
0.79 (0.41,1.52) |
0.99 (0.53,1.84) |
2.10 (1.09,3.84) |
| 1.74 (1.15,2.70) |
1.32 (0.56,2.33) |
1.27 (0.66,2.45) |
榫眼3莫+ P2Y12 |
1.26 (0.72,2.16) |
2.67 (1.50,4.52) |
| 1.39 (1.00,1.99) |
1.04 (0.48,1.80) |
1.01 (0.54,1.90) |
0.79 (0.46,1.39) |
榫眼6个月 |
2.10 (1.42,3.10) |
| 0.65 (0.47,0.96) |
0.50 (0.23,0.85) |
0.48 (0.26,0.91) |
0.37 (0.22,0.67) |
0.48 (0.32,0.71) |
L-DAPT |
|
|
|
结果上三角形的优势比为95%的置信区间之间的网络荟萃分析列定义干预和行定义干预。大胆的重要结果。L-DAPT指长期(> 18个月)榫眼,榫眼12密苏里州指的是12个月的榫眼,榫眼6 mo指的是6个月榫眼,榫眼3莫+ ASA指三个月榫眼紧随其后的是阿司匹林单一疗法,榫眼3莫+ P2Y12指三个月榫眼后跟P2Y12受体抑制剂单一疗法,和榫眼1 mo + P2Y12指月榫眼P2Y12受体抑制剂单一疗法。榫眼表明双重抗血小板治疗。
|
